PATENT CLAIM ANALYSIS

Application Number: 15921596
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["514", "021900"]

Abstract:
Pyrrolidine carboxamido derivatives, optical isomers thereof, and salts thereof that are able to prevent, improve, and/or treat inflammatory conditions, including inflammatory bowel disease, and methods for preparing and using the same are provided.

Claim (Index 4):
The method of  claim 1 , wherein the composition, wherein the composition inhibits formation of an inflammatory signal transduction complex mediated by MyD88, inhibits formation of an inflammatory signal transduction complex mediated by Pellino-1, inhibits formation of an inflammatory signal transduction complex mediated by Rip1, suppresses expression of at least one protein selected from the group consisting of G-CSF, IL-2, SCF, VEGF, CX3CL1, IGFBP5, IGFBP6, IL-1\u03b1, IL-1\u03b2, IL-6, IL-9, MCP-1, MIP-3\u03b1, IL12p40/70, MIG, TNF-\u03b1, and VCAM-1, or suppresses activity of N F-\u03baB.

Metadata:
- Claim Count in Document: 43.0
- Percentile: 90.0
- Lexical Diversity: 1.33333
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['11122989', '12786221', '15497822', '11482855', '14649902']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7813490570560969
- 35 USC 102 Novelty (BERT): 0.5161277770612245
- Combined Prediction Score: 0.7548269290566098
- Mean Citation Score: 197.153088
- Max Citation Score: 204.18689
- Similarity Product: 100.54187828842284

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test